Dow Up 0.11% Nasdaq Up 0.50%

CytRx Corporation (CYTR)

-NasdaqCM
3.32 Down 0.05(1.48%) Aug 29, 4:00PM EDT
|After Hours : 3.32 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Prev Close:3.37
Open:3.39
Bid:3.02 x 1200
Ask:N/A
1y Target Est:11.00
Beta:1.06
Next Earnings Date:N/A
Day's Range:3.27 - 3.42
52wk Range:2.00 - 8.35
Volume:519,309
Avg Vol (3m):1,355,570
Market Cap:185.09M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRDown 1.48%185.09M
LLYUp 0.71%68.12B
NVSUp 0.12%217.97B
SNY 0.00%143.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,878.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback